Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10737090 | Experimental Gerontology | 2005 | 7 Pages |
Abstract
The result showed an increase in oncostatin M, interleukin-1β (IL-1β) and interleukin-6 (IL-6) secretion in AD patients compared to healthy controls, and a decrease of cytokine levels in each AD patients treated for 1 month with an acetylcholinesterase inhibitor (AchEI). In conclusion, the results of this study show that the complex pathology in AD may be reflected in a pattern of altered cytokine secretion from PBMC.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Marcella Reale, Carla Iarlori, Francesco Gambi, Isabella Lucci, Mirella Salvatore, Domenico Gambi,